Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay
- 15 May 2014
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 28 (8) , 1227-1232
Abstract
Objectives: To evaluate factors associated with misclassification by the limiting-antigen avidity (LAg-avidity) assay among individuals with long-standing HIV infection. Design: Samples were obtained from the Multicenter AIDS Cohort Study and AIDS Linked to the IntraVenous Experience cohort (1089 samples from 667 individuals, 595 samples collected 2–4 years and 494 samples collected 4–8 years after HIV seroconversion). Paired samples from both time points were available for 422 (63.3%) of the 667 individuals. Methods: Samples were considered to be misclassified if the LAg-avidity assay result was 1.5 or less normalized optical density (OD-n) units. Results: Overall, 4.8% (52/1089) of the samples were misclassified, including 1.8% [16/884, 95% confidence interval (CI) 1.09–3.06%] of samples from individuals with viral loads above 400 copies/ml and 1.4% (10/705) of samples from individuals with viral loads above 400 copies/ml and CD4+ cell counts above 200 cells/μl (95% CI 0.68–2.60%). Age, race, sex, and mode of HIV acquisition were not associated with misclassification. In an adjusted analysis, viral load below 400 copies/ml [adjusted odds ratio (aOR) 3.72, 95% CI 1.61–8.57], CD4+ cell count below 50 cells/μl (aOR 5.41, 95% CI 1.86–15.74), and low LAg-avidity result (≤1.5 OD-n) from the earlier time point (aOR 5.60, 95% CI 1.55–20.25) were significantly associated with misclassification. Conclusions: The manufacturer of the LAg-avidity assay recommends excluding individuals from incidence surveys who are receiving antiretroviral therapy, are elite suppressors, or have AIDS (CD4+ cell count <200 cells/μl). The results of this study indicate that those exclusions do not remove all sources of assay misclassification among individuals with long-standing HIV infection.Keywords
This publication has 26 references indexed in Scilit:
- Estimation of HIV Incidence in a Large, Community-Based, Randomized Clinical Trial: NIMH Project Accept (HIV Prevention Trials Network 043)PLOS ONE, 2013
- Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B InfectionPLOS ONE, 2013
- Non-disclosure of HIV status in UK sexual health clinics—a pilot study to identify non-disclosure within a national unlinked anonymous seroprevalence surveySexually Transmitted Infections, 2013
- HIV Incidence Determination in the United States: A Multiassay ApproachThe Journal of Infectious Diseases, 2012
- Detection of Recent HIV-1 Infection Using a New Limiting-Antigen Avidity Assay: Potential for HIV-1 Incidence Estimates and Avidity Maturation StudiesPLOS ONE, 2012
- Effect of CD4 + T Cell Count and Antiretroviral Treatment on Two Serological HIV Incidence AssaysAIDS Research and Human Retroviruses, 2012
- Avidity Index for Anti-HIV Antibodies: Comparison between Third- and Fourth-Generation Automated ImmunoassaysJournal of Clinical Microbiology, 2011
- HIV Incidence Estimation Using the BED Capture Enzyme ImmunoassayEpidemiology, 2010
- Development and Validation of an Immunoassay for Identification of Recent Human Immunodeficiency Virus Type 1 Infections and Its Use on Dried Serum SpotsJournal of Clinical Microbiology, 2005
- THE MULTICENTER AIDS COHORT STUDY: RATIONALE, ORGANIZATION, AND SELECTED CHARACTERISTICS OF THE PARTICIPANTSAmerican Journal of Epidemiology, 1987